CalciMedica (CALC) vs Jaguar Health (JAGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CalciMedica is the larger company by market cap ($9.2 million vs $8.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CALC | JAGX |
|---|---|---|
| Share price | $1.35 | $4.43 |
| Market cap | $9.22M | $8.63M |
| 1-day change | -8.78% | -11.33% |
| YTD return | -95.51% | — |
| 1-year return | -91.27% | — |
| EPS (TTM) | $-6.85 | $-4,012.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $36.00 | $1,267.88 |
| 52-week low | $1.34 | $2.35 |
| Distance from 52-week high | -96.25% | -99.65% |
| Average volume | 73.03K | 2.00M |
| Shares outstanding | 6.83M | 1.95M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CALC vs JAGX FAQ
Which is bigger, CalciMedica or Jaguar Health?
CalciMedica (CALC) is larger, with a market capitalization of $9.22M compared with $8.63M for Jaguar Health (JAGX).
Are CalciMedica and Jaguar Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.